Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1751566Generated: October 28, 2026

Bis(pinacolato)diborane → (R)-tert-butyl 4-(5-(4-(6-(2-((S)-1-((S)-2-(methoxycarbonylamino)-3-methylbutanoyl)pyrrolidin-2-yl)-1H-imidazol-5-yl)naphthalen-2-yl)phenyl)-1H-imidazol-2-yl)oxazolidine-3-carboxylate

https://huagongshe.com/reaction/1751566

Reaction equation

Participants

RoleNameHCIDCharge
ReactantBis(pinacolato)diboraneHCID 2733548—
Reactantmethyl (S)-1-((S)-2-(5-(6-bromonaphthalen-2-yl)-1H-imidazol-2-yl)pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-ylcarbamateHCID 59610262—
Reactant((S)-1-{(S)-8-[4-(4-Bromo-phenyl)-1H-imidazol-2-yl]-1,4-dioxa-7-aza-spiro[4.4]nonane-7-carbonyl}-2-methyl-propyl)-carbamic acid methyl esterHCID 59610362—
Reactant(R)-tert-butyl 4-(5-(4-bromophenyl)-1H-imidazol-2-yl)oxazolidine-3-carboxylateHCID 69675519—
Reactant(S)-tert-butyl 2-(7-bromo-1H-naphtho[1,2-d]imidazol-2-yl)pyrrolidine-1-carboxylateHCID 178451893—
ReactantHCID 178502289HCID 178502289—
Product(R)-tert-butyl 4-(5-(4-(6-(2-((S)-1-((S)-2-(methoxycarbonylamino)-3-methylbutanoyl)pyrrolidin-2-yl)-1H-imidazol-5-yl)naphthalen-2-yl)phenyl)-1H-imidazol-2-yl)oxazolidine-3-carboxylateHCID 69675250—

Reaction Steps

The title compound was prepared according to the method employed to prepare (S)-Tert-butyl 2-(7-(4-(2-((S)-7-((S)-2-(methoxycarbonylamino)-3-methylbutanoyl)-1,4-dioxa-7-azaspiro[4.4]nonan-8-yl)-1H-imidazol-5-yl)phenyl)-1H-naphtho[1,2-d]imidazol-2-yl)pyrrolidine-1-carboxylate, except that, respectively, methyl (S)-1-((S)-2-(5-(6-bromonaphthalen-2-yl)-1H-imidazol-2-yl)pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-ylcarbamate and (R)-tert-butyl 4-(5-(4-bromophenyl)-1H-imidazol-2-yl)oxazolidine-3-carboxylate were used instead of methyl (S)-1-((S)-8-(5-(4-bromophenyl)-1H-imidazol-2-yl)-1,4-dioxa-7-azaspiro[4.4]nonan-7-yl)-3-methyl-1-oxobutan-2-ylcarbamate (100 mg, 0.197 mmol), bis(pinacolato)diboron and (S)-tert-butyl 2-(7-bromo-1H-naphtho[1,2-d]imidazol-2-yl)pyrrolidine-1-carboxylate. MS (ESI) m/z 734.91 [M+H]+. (110 mg, 45%).

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS09156823B2
Source datasetuspto-grants-2015_10
ORD IDord-43315b0e73c743e194be5c1df6edd8d9
Source noteuspto-grants-2015_10